[1]谭亚军, 张庶民等.多糖蛋白结合疫苗中载体蛋白的研究与应用[J].中国疫苗和免疫, 2013, 19(4):355-360
[2]Tan Y J, Zhang S M, et al.The research and application of carrier protein in polysaccharide conjugate vaccine[J].Chinese Journal of Vaccines and Immunization, 2013, 19(4):355-360
[3]王铭, 魏云林, 马波等.重组白喉毒素无毒突变体柱复性及纯化工艺的优化[J].中国生物制品学杂志, 2014, 27(007):945-949
[4]Wang M, Wei Y L, Ma B, et al.Optimization of recombinant diphtheria non-toxic mutant CRM _ (197) in column renaturation and purification process[J].Chinese Journal of Biologicals, 2014, 27(007):945-949
[5]Br?ker M, Dull P M, Rappuoli R, et al.Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages[J].Vaccine, 2009, 27(41):5574-5580
[6] 王春娥.白喉无毒变异体CRM197:的克隆、表达、纯化及作为结合疫苗蛋白载体的初步应用[D], 北京:中国药品生物制品检定所, 2007
[7]Wang C E.Diphtheria nontoxic mutant CRM197: Clone, , purification and the preliminary application as a carrier protein in conjugate vaccine [D]. Beijing: Chinese Biological Products Institute, 2007
[8]Uchida T, Pappenheimer AM Jr, Greany R.Diphtheria toxin and related proteins[J].Isolation and properties of mutant proteins serologically related to diphtheria toxin. Journal of biological chemistry, 1973, 248(11):3838-3844
[9]Micolia F, Rondini S, et al.Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi[J][J].vaccine, 2011, 29:712-720
[10]Shinefield H R.Overview of the development and current use of CRM197 conjugate vaccines for pediatric use[J].Vaccine, 2010, 28(27):4335-4339
[11] 赵雪娜, 董相陈, 侯登勇, 等.白喉毒素突变体 CRM197在大肠杆菌中表达纯化及性质研究[J], 2010, 1:153-156[J].生物技术通报, 2010, 1:153-156
[12]Zhao X N, Dong X C, Hou D Y, et al.Study on purification and of CRM197 in Escherichia coli[J], 2010, 1:153-156[J].Biotechnology Bulletin, 2010, 1:153-156
[13]Rappuoli R.Isolation and characterization of Corynebacterium diphtheriae nontandem double lysogens hyperproducing CRM197[J].Applied and environmental microbiology, 1983, 46(3):560-564
[14] Hedari C P, Khinkarly R W, Dbaibo G S.Meningococcal Serogroups a, C, W-135, and Y Tetanus Toxoid Conjugate Vaccine: A New Conjugate Vaccine against Invasive Meningococcal Disease.[J][J].Infect Drug Resist, 2014, 7:85-99
[15]周宇, 赵兆, 袁涛, 等.白喉毒素无毒突变体 基因的克隆与表达[J].微生物学免疫学进展, 2014, 42(3):18-21
[16]Zhou Y, Zhao Z, Yuan T, et al.Clone and of nontoxic diphtheria toxin mutant CRM197[J].Progress in Microbiology and Immunology, 2014, 42(3):18-21
[17]王钢, 陈尘, 李强.大肠杆菌体系外源蛋白表达速度的调控策略[J].过程工程学报, 2013, 13(6):1075-1080
[18]Wang G, Chen C, Li q.Strategies for regulating the of foreign proteins in Escherichia coli[J].The Chinese Journal of Process Engineering, 2013, 13(6):1075-1080
[19]谭伟, 谢芝勋.甲型流感病毒 通用疫苗的研究进展[J].生物技术通讯, 2014, 25(6):857-861
[20]Tan W, Xie Z X.Research progress of influenza A virus M2e universal vaccine[J].Letters in Biotechnology, 2014, 25(6):857-861
[21]王鹤 陈则.基于基质蛋白的通用流感疫苗研究现状[J].国际生物制品学杂志, 2014, 37(4):188-193
[22]Wang H, Chen Z.Research status of universal influenza vaccine based on matrix protein 2[J].International Journal of Biologicals, 2014, 37(4):188-193
[23]Fan J, Liang X, Horton M S, et al.Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice,ferrets,and rhesus monkeys[J].Vaccine, 2004, 22(23):2993-3003
[24]Liu X, Guo J, Han S, et al.Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin[J].Vaccine, 2012, 30(46):6527-6533
[25] 肖钾钙镁.白喉毒素CRM197的表达纯化及性质研究[D]. 天津:天津商业大学, 2012
[26]Xiao J G M.The research about, purification and properties of diphtheria toxin CRM197[D]. Tianjin: Tianjin University of Commerce, 2012
[27] E.保罗. 基础免疫学[M]. 吴玉章译. 北京:科学出版社, 2007:914-940
[28]Paul W E.Fundamental Immunology Fourth Edition[M]. Beijing, Science Press, 2007: 914-940
[29]王春娥, 叶强, 李凤祥.白喉毒素无毒变异体 的表达及其载体作用[J].中国生物制品学杂志, 2008, 21(8):687-691
[30]Wang C E, Ye Q, Li F X.The and role as carrier protein of diphtheria nontoxic mutant CRM197[J].Chinese Journal of Biologicals, 2008, 21(8):687-691
[31]Deng L, Cho K J, Fiers W, et al.M2e-based universal influenza A vaccines[J].Vaccines, 2015, 3(1):105-136
|